NANETS Symposium
Neuroendocrine tumors have been considered a rare disease; however, data suggests that the diagnosed incidence of neuroendocrine tumors has continued to increase over the last decade. There was a 5 fold increase over a 30 year period (1973-2004) and NETs of the small bowel in 2014 are the most common small bowel malignancy. In addition, there are more patients living with NETs than stomach and pancreas tumors combined. Diagnosing, assessing and managing NET patients is very time consuming and requires a multidisciplinary approach. Most community physicians do not have the time, expertise, experience or resources to adequately address these complicated cases yet with this increasing number of neuroendocrine tumor patients many are seeking care from physicians who may have little knowledge or experience with this disease. As a result, there is a necessity for leading oncologists & physicians in carcinoid and neuroendocrine tumors to address this knowledge deficit.
Additionally, significant developments in diagnosis, loco-regional and systemic therapy are rapidly being developed. Consequently there is a clear need for physicians and allied health care providers to learn about the standard management of patients with neuroendocrine tumors, sequence of treatments and to familiarize themselves with new therapeutic approaches to these diseases. The intent of the conference is to provide up to date evidence based practice to health care professionals involved in the diagnosis and management of the patients living with this malignancy. Ultimately this will result in a tremendous benefit to the patient population by improved outcomes and survival.
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and NANETS. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 7.25 hours of participation for continuing education for allied health professionals.
Target Audience
Physicians and other health professionals in the following specialties: oncology, endocrinology, surgery, pathology, internal medicine, gastroenterology, nuclear medicine, nursing, nutrition, diagnostic radiology, interventional radiology and primary care.
Learning Objectives
Interpret current advances in the histopathology of both primary & metastatic NETs and how classification determines diagnostic approach, management and prognosis; |
Utilize the proper assays & diagnostic techniques for identifying and monitoring NET diseases; |
Describe the various surgical interventions for different NET sites and define the importance of incorporating an evaluation by an experienced NET surgeon into the patient’s ongoing treatment strategy; |
Evaluate the safety and efficacy of image guided diagnostics or treatment and determine when to integrate the procedure (s) into a patient’s treatment plan; |
Specify the risks and benefits of each liver directed therapy based on patient-specific information; |
Identify the numerous syndromes associated with neuroendocrine tumors and define the symptoms related to each condition |
Compare the clinical effectiveness of the different targeted therapies and radiotherapeutic approaches to assess which intervention would be most appropriate for patients with different neuroendocrine tumors; |
Illustrate the value of creating a multidisciplinary team and communication system to improve the quality of care for the NET patients. |
Murad Aburajab, MD
Assistant Professor
Division of Gastroenterology & Hepatology
Medical College of Wisconsin
Ty Carroll, MD
Assistant Professor
Division of Endocrinology, Department of Medicine
Medical College of Wisconsin
Kathleen K. Christians, MD, FACS
Professor of Surgery
Division of Surgical Oncology
Medical College of Wisconsin
Douglas B. Evans, MD
Donald C. Ausman Family Foundation Professor of Surgery
Chair, Department of Surgery
Medical College of Wisconsin
Jenny Geurts, MS, CGC
Certified Genetic Counselor Manager
Genetic Counseling Program Human & Molecular Genetics Center
Medical College of Wisconsin
Carrie Peterson, MD
Assistant Professor
Division of Colorectal Surgery
Medical College of Wisconsin
William S. Rilling, MD, FSIR
Professor of Radiology and Surgery
Department of Radiology, Division of Vascular & Interventional Radiology
Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital
Laura H. Tang, MD, PhD
Pathologist, Department of Pathology
Memorial Sloan-Kettering Cancer Center
James P. Thomas, MD, PhD
Associate Director, Translational Research Medical Director
Clinical Trials Office Section Head, Solid Tumor Oncology
Professor of Medicine, Division of Hematology and Oncology
Medical College of Wisconsin
Parag P. Tolat, MD
Section Chief, Abdominal/Body Imaging Section
Department of Radiology
Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital
Susan Tsai, MD, MHS
Assistant Professor of Surgery
Division of Surgical Oncology
Medical College of Wisconsin
James C. Yao, MD
Gastroenterologist
The University of Texas MD Anderson Cancer Center Chair
Division of Cancer Medicine Division
MD Anderson Cancer Center Professor
Department of Gastrointestinal Medical Oncology
Available Credit
- 7.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 7.25 Hours of ParticipationHours of Participation credit.